Guangdong Taiantang Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 708.97 million compared to CNY 2,181.43 million a year ago. Revenue was CNY 724.84 million compared to CNY 2,264.17 million a year ago.

Net loss was CNY 822.82 million compared to CNY 803.29 million a year ago. Basic loss per share from continuing operations was CNY 1.07 compared to CNY 1.05 a year ago. Diluted loss per share from continuing operations was CNY 1.07 compared to CNY 1.05 a year ago.